1. Chigwedere P, Seage GR, Gruskin S, Lee T-H. Estimating the lost benefits of antiretroviral drug use in South Africa. Perspectives: Epidemiology and Social Science. J Acquir Immune Defic Syndr. 2008;49:410–5 (accessed 28 January 2015).
2. Heywood, M. 2004 Price of Denial. Development Update 5(3). Interfund. http://www.tac.org.za/Documents/PriceOfDenial.doc . Accessed 30 Jan 2015.
3. Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Labadarios D, et al. South African national HIV prevalence, incidence and behaviour survey, 2012. Cape Town: HSRC Press; 2014.
4. Department of Health. The 2012 National Antenatal Sentinel HIV and Herpes Simplex type-2 prevalence Survey. South African National Department of Health; 2013.
5. McNeil J. A History of Official Government HIV/AIDS Policy in South Africa. South African History Archives. Available at: http://www.sahistory.org.za/topic/history-official-government-hivaids-policy-south-africa .